effect of plantago major on severity of cought

The efficacy of Plantago major syrup on severity of cough in acute bronchitis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200105046009N2

Enrollment

Registered

2020-07-12

Start date

2020-08-05

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brunchit. Acute bronchiolitis

Interventions

Intervention 1: Intervention group: Plantago major syrup containing extract of the seed of Plantago major, made by Sanabel Daru Company is used. Syrups are given to the patient on a weekly basis in 3

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: age between 20 t0 75 years old acute cough clinical diagnosis of acute bronchitis

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Patients who took a cough and sputum medication for one week before the study History of respiratory disease such as chronic bronchitis, bronchiectasis, asthma-pneumonia, cystic fibrosis, lung cancers or active pulmonary tuberculosis Kidney or liver failure Genetic diseases such as galactose intolerance or lactose intolerance History or presence of cardiovascular disease, neurological disease, metabolic disease or mental disorders. Hematologic disease or malignant tumor (unless recurrent within 5 years) A history of alcohol or substance abuse

Design outcomes

Primary

Measure	Time frame
Severity of acute bronchitis. Timepoint: Assessing patients at the first visit (before starting the study), on the fifth day and on the tenth day after starting treatment. Method of measurement: Bronchitis Severity Score (BSS) questionnaire.	—

Secondary

Measure	Time frame
Quality of life for acute cough. Timepoint: Before starting treatment, after the end of treatment. Method of measurement: Standard Quality of Life Questionnaire for Acute Cough (Leicester Cough Questionnaire).;Severity of cough. Timepoint: Assessing patients at the first visit (before starting the study), on the fifth day and on the tenth day after starting treatment. Method of measurement: cough evaluating questionnaire based on Visual Analog Scales.	—

Measure

Time frame

Quality of life for acute cough. Timepoint: Before starting treatment, after the end of treatment. Method of measurement: Standard Quality of Life Questionnaire for Acute Cough (Leicester Cough Questionnaire).;Severity of cough. Timepoint: Assessing patients at the first visit (before starting the study), on the fifth day and on the tenth day after starting treatment. Method of measurement: cough evaluating questionnaire based on Visual Analog Scales.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed Ali Mozaffarpur

Babol University of Medical Sciences

seyyedali1357@gmail.com+98 11 3219 4728

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026